Scientific paper - Review paper
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
Cardiovascular Diabetology, 18 (2019), 1; https://doi.org/10.1186/s12933-019-0864-7

Fruchart, Jean-Charles; Santos, Raul D.; Aguilar-Salinas, Carlos; Aikawa, Masanori; Al Rasadi, Khalid; Amarenco, Pierre; Barter, Philip J.; Ceska, Richard; Corsini, Alberto; Després, Jean-Pierre; Duriez, Patrick; Eckel, Robert H.; Ezhov, Marat V.; Farnier, Michel; Ginsberg, Henry N.; Hermans, Michel P.; Ishibashi, Shun; Karpe, Fredrik; Kodama, Tatsuhiko; Koenig, Wolfgang; Krempf, Michel; Lim, Soo; Lorenzatti, Alberto J.; McPherson, Ruth; Nuñez-Cortes, Jesus Millan; Nordestgaard, Børge G.; Ogawa, Hisao; Packard, Chris J.; Plutzky, Jorge; Ponte-Negretti, Carlos I.; Pradhan, Aruna; Ray, Kausik K.; Reiner, Željko; Ridker, Paul M.; Ruscica, Massimiliano; Sadikot, Shaukat; Shimano, Hitoshi; Sritara, Piyamitr; Stock, Jane K.; Su, Ta-Chen; Susekov, Andrey V.; Tartar, André; Taskinen, Marja-Riitta; Tenenbaum, Alexander; Tokgözoğlu, Lale S.; Tomlinson, Brian; Tybjærg-Hansen, Anne; Valensi, Paul; Vrablík, Michal; Wahli, Walter; Watts, Gerald F.; Yamashita, Shizuya; Yokote, Koutaro; Zambon, Alberto; Libby, Peter More authors...

Cite this document

Fruchart, J. C., Santos, R. D., Aguilar Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P. ... Libby, P. (2019). The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential. Cardiovascular Diabetology, 18. (1). doi: 10.1186/s12933-019-0864-7

Fruchart, Jean Charles, et al. "The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential." Cardiovascular Diabetology, vol. 18, no. 1, 2019. https://doi.org/10.1186/s12933-019-0864-7

Fruchart, Jean Charles, Raul D. Santos, Carlos Aguilar Salinas, Masanori Aikawa, Khalid Al Rasadi, Pierre Amarenco, Philip J. Barter, et al. "The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential." Cardiovascular Diabetology 18, no. 1 (2019). https://doi.org/10.1186/s12933-019-0864-7

Fruchart, J. C., et al. (2019) 'The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential', Cardiovascular Diabetology, 18(1). doi: 10.1186/s12933-019-0864-7

Fruchart JC, Santos RD, Aguilar Salinas C, Aikawa M, Al Rasadi K, Amarenco P, and sur.. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential. Cardiovascular Diabetology [Internet]. 2019 June 04 [cited 2024 July 04];18(1). doi: 10.1186/s12933-019-0864-7

J. C. Fruchart, et al., "The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential", Cardiovascular Diabetology, vol. 18, no. 1, June 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:859241. [Accessed: 04 July 2024]

Please login to the repository to save this object to your list.